EcoDrugPlus

Coagulation Factor Ii Thrombin Receptor

Ensembl ID : ENSSAUG00010005731
Gene Symbol: F2R
1 Cross references
258 Possible Orthologues:

Coagulation Factor Ii Thrombin Receptor

Ensembl ID : ENSSAUG00010005740
Gene Symbol: F2R
1 Cross references
258 Possible Orthologues:

Coagulation Factor Ii Thrombin Receptor

Ensembl ID : ENSSAUG00010000440
Gene Symbol: F2R
3 Cross references
216 Possible Orthologues:

Coagulation Factor Ii Thrombin Receptor

Ensembl ID : ENSSAUG00010005733
Gene Symbol: F2R
1 Cross references
258 Possible Orthologues:

Coagulation Factor Ii Thrombin Receptor

Ensembl ID : ENSSAUG00010005734
Gene Symbol: F2R
1 Cross references
258 Possible Orthologues:

Coagulation Factor Ii Thrombin Receptor

Ensembl ID : ENSSAUG00010005737
Gene Symbol: F2R
1 Cross references
258 Possible Orthologues:

Coagulation Factor Iii, Tissue Factor

Ensembl ID : ENSSAUG00010019712
Gene Symbol: F3
3 Cross references
199 Possible Orthologues:

Coagulation Factor Vii, Like

Ensembl ID : ENSSAUG00010006447
Gene Symbol: F7L
1 Cross references
78 Possible Orthologues:

Coagulation Factor X

Ensembl ID : ENSSAUG00010006383
Gene Symbol: F10
1 Cross references
240 Possible Orthologues:

Coiled-Coil Domain Containing 6a

Ensembl ID : ENSSAUG00010027130
Gene Symbol: CCDC6A
1 Cross references
207 Possible Orthologues:

Collagenase 3-Like

Ensembl ID : ENSSAUG00010014696
Gene Symbol: LOC115594788
2 Cross references
194 Possible Orthologues:

Collagenase 3-Like

Ensembl ID : ENSSAUG00010014101
Gene Symbol: LOC115594790
3 Cross references
278 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).